FDA PANEL VOTES TO KEEP BREAST IMPLANTS ON MARKET
FDA PANEL VOTES TO KEEP BREAST IMPLANTS ON MARKET SANTA BARBARA, Calif., Nov. 15 /PRNewswire/ -- Mentor Corp.
(NASDAQ: MNTR) today announced that an advisory panel to the United States Food and Drug Administration (FDA) unanimously voted yesterday that silicone gel-filled breast implants should remain on the market while the agency gathers more data on the safety and efficacy of the products.
The panel recommended that Mentor be allowed to continue to sell its devices, which are used in the reconstruction of breasts lost to cancer and surgery for breast augmentation, while the FDA evaluates additional data, including results from industry studies currently under way. -0- 11/15/91 /CONTACT: Chris Conway, CEO of Mentor Corp., 805-967-3451/ (MNTR) CO: Mentor Corp.; U.S. Food and Drug Administration ST: California IN: MTC SU: CH -- LA007 -- 1502 11/15/91 11:33 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 15, 1991|
|Previous Article:||GENERAL MAGNAPLATE REPORTS FIRST QUARTER RESULTS|
|Next Article:||COMERICA ACQUIRES MIDLANTIC TRUST AND LENDING BUSINESS, EXPANDS FLORIDA OPERATIONS|